Riverside Invests in Avance Clinical
Avance provides global regulatory standard clinical research services across all phases to the local and international biopharma industry. The company is also accredited as a gene technology CRO under the Office of the Gene Technology Regulator (OGTR), which has allowed it to expand into clinical trials for vaccines and GMO therapies.
The Premium Lower and Middle Market M&A Platform
For full transactional data, join PrivSource today!Apply →